Stockreport

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 4, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company [Read more]